Wnt5a skews dendritic cell differentiation to an unconventional phenotype with tolerogenic features

Journal of Immunology

Volumn 187, Issue 8, 2011, Pages 4129-4139

  Valencia, Jaris ^a   Hernández López, Carmen ^a   Martínez, Víctor G ^a   Hidalgo, Laura ^a   Zapata, Agustín G ^a   Vicente, Ángeles ^a   Varas, Alberto ^a   Sacedón, Rosa ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 6; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; WNT5A PROTEIN;

ARTICLE; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN CELL; MONOCYTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; SEPSIS; SIGNAL TRANSDUCTION; TH1 CELL;

CELL DIFFERENTIATION; CELL SEPARATION; CELLS, CULTURED; DENDRITIC CELLS; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNE TOLERANCE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE TEST, MIXED; MONOCYTES; PHENOTYPE; PROTO-ONCOGENE PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WNT PROTEINS;

EID: 80054730000     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1101243     Document Type: Article

References (50)

1. Coquerelle, C., and M. Moser. 2010. DC subsets in positive and negative regulation of immunity. Immunol. Rev. 234: 317-334.
2. Ueno, H., N. Schmitt, E. Klechevsky, A. Pedroza-Gonzalez, T. Matsui, G. Zurawski, S. Oh, J. Fay, V. Pascual, J. Banchereau, and K. Palucka. 2010. Harnessing human dendritic cell subsets for medicine. Immunol. Rev. 234: 199-212.
3. Naik, S. H. 2008. Demystifying the development of dendritic cell subtypes, a little. Immunol. Cell Biol. 86: 439-452. (Pubitemid 351948216)
4. Jiang, A., O. Bloom, S. Ono, W. Cui, J. Unternaehrer, S. Jiang, J. A. Whitney, J. Connolly, J. Banchereau, and I. Mellman. 2007. Disruption of E-cadherin-mediated adhesion induces a functionally distinct pathway of dendritic cell maturation. Immunity 27: 610-624. (Pubitemid 47615505)
5. Zhou, J., P. Cheng, J. I. Youn, M. J. Cotter, and D. I. Gabrilovich. 2009. Notch and wingless signaling cooperate in regulation of dendritic cell differentiation. Immunity 30: 845-859.
6. Manicassamy, S., B. Reizis, R. Ravindran, H. Nakaya, R. M. Salazar-Gonzalez, Y. C. Wang, and B. Pulendran. 2010. Activation of beta-catenin in dendritic cells regulates immunity versus tolerance in the intestine. Science 329: 849-853.
7. van Amerongen, R., and R. Nusse. 2009. Towards an integrated view of Wnt signaling in development. Development 136: 3205-3214.
8. Hoeppner, L. H., F. J. Secreto, and J. J. Westendorf. 2009. Wnt signaling as a therapeutic target for bone diseases. Expert Opin. Ther. Targets 13: 485-496.
9. Ouchi, N., A. Higuchi, K. Ohashi, Y. Oshima, N. Gokce, R. Shibata, Y. Akasaki, A. Shimono, and K. Walsh. 2010. Sfrp5 is an anti-inflammatory adipokine that modulates metabolic dysfunction in obesity. Science 329: 454-457.
10. Staal, F. J., and T. C. Luis. 2010. Wnt signaling in hematopoiesis: crucial factors for self-renewal, proliferation, and cell fate decisions. J. Cell. Biochem. 109: 844-849.
11. Wend, P., J. D. Holland, U. Ziebold, and W. Birchmeier. 2010. Wnt signaling in stem and cancer stem cells. Semin. Cell Dev. Biol. 21: 855-863.
12. Brack, A. S., M. J. Conboy, S. Roy, M. Lee, C. J. Kuo, C. Keller, and T. A. Rando. 2007. Increased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis. Science 317: 807-810. (Pubitemid 47257918)
13. Liu, H., M. M. Fergusson, R. M. Castilho, J. Liu, L. Cao, J. Chen, D. Malide, I. I. Rovira, D. Schimel, C. J. Kuo, et al. 2007. Augmented Wnt signaling in a mammalian model of accelerated aging. Science 317: 803-806. (Pubitemid 47257917)
14. Pereira, C., D. J. Schaer, E. B. Bachli, M. O. Kurrer, and G. Schoedon. 2008. Wnt5A/CaMKII signaling contributes to the inflammatory response of macrophages and is a target for the antiinflammatory action of activated protein C and interleukin-10. Arterioscler. Thromb. Vasc. Biol. 28: 504-510.
15. Rao, T. P., and M. Kühl. 2010. An updated overview on Wnt signaling pathways: a prelude for more. Circ. Res. 106: 1798-1806.
16. Gao, C., and Y. G. Chen. 2010. Dishevelled: The hub of Wnt signaling. Cell. Signal. 22: 717-727.
17. Wu, D., and W. Pan. 2010. GSK3: a multifaceted kinase in Wnt signaling. Trends Biochem. Sci. 35: 161-168.
18. Beurel, E., S. M. Michalek, and R. S. Jope. 2010. Innate and adaptive immune responses regulated by glycogen synthase kinase-3 (GSK3). Trends Immunol. 31: 24-31.
19. Beurel, E., W. I. Yeh, S. M. Michalek, L. E. Harrington, and R. S. Jope. 2011. Glycogen synthase kinase-3 is an early determinant in the differentiation of pathogenic Th17 cells. J. Immunol. 186: 1391-1398.
20. Wu, B., S. P. Crampton, and C. C. Hughes. 2007. Wnt signaling induces matrix metalloproteinase expression and regulates T cell transmigration. Immunity 26: 227-239. (Pubitemid 46329437)
21. Neumann, J., K. Schaale, K. Farhat, T. Endermann, A. J. Ulmer, S. Ehlers, and N. Reiling. 2010. Frizzled1 is a marker of inflammatory macrophages, and its ligand Wnt3a is involved in reprogramming Mycobacterium tuberculosis- infected macrophages. FASEB J. 24: 4599-4612.
22. Blumenthal, A., S. Ehlers, J. Lauber, J. Buer, C. Lange, T. Goldmann, H. Heine, E. Brandt, and N. Reiling. 2006. The Wingless homolog WNT5A and its receptor Frizzled-5 regulate inflammatory responses of human mononuclear cells induced by microbial stimulation. Blood 108: 965-973. (Pubitemid 44154632)
23. Kim, J., J. Kim, D. W. Kim, Y. Ha, M. H. Ihm, H. Kim, K. Song, and I. Lee. 2010. Wnt5a induces endothelial inflammation via beta-catenin-independent signaling. J. Immunol. 185: 1274-1282.
24. Sen, M. 2005. Wnt signalling in rheumatoid arthritis. Rheumatology (Oxford) 44: 708-713. (Pubitemid 41487197)
25. Rodionova, E., M. Conzelmann, E. Maraskovsky, M. Hess, M. Kirsch, T. Giese, A. D. Ho, M. Zöller, P. Dreger, and T. Luft. 2007. GSK-3 mediates differentiation and activation of proinflammatory dendritic cells. Blood 109: 1584-1592. (Pubitemid 46239592)
26. Martínez, V. G., C. Hernández-López, J. Valencia, L. Hidalgo, A. Entrena, A. G. Zapata, A. Vicente, R. Sacedón, and A. Varas. 2011. The canonical BMP signaling pathway is involved in human monocyte-derived dendritic cell maturation. Immunol. Cell Biol. 89: 610-618.
27. Valencia, J., C. Hernández-López, V. G. Martínez, L. Hidalgo, A. G. Zapata, A. Vicente, A. Varas, and R. Sacedón. 2010. Transient beta-catenin stabilization modifies lineage output from human thymic CD34+CD1a- progenitors. J. Leukoc. Biol. 87: 405-414.
28. Liu, J., S. Cao, S. Kim, E. Y. Chung, Y. Homma, X. Guan, V. Jimenez, and X. Ma. 2005. Interleukin-12: an update on its immunological activities, signaling and regulation of gene expression. Curr. Immunol. Rev. 1: 119-137.
29. Chomarat, P., J. Banchereau, J. Davoust, and A. K. Palucka. 2000. IL-6 switches the differentiation of monocytes from dendritic cells to macrophages. Nat. Immunol. 1: 510-514.
30. Chomarat, P., C. Dantin, L. Bennett, J. Banchereau, and A. K. Palucka. 2003. TNF skews monocyte differentiation from macrophages to dendritic cells. J. Immunol. 171: 2262-2269. (Pubitemid 37028309)
31. Kühl, M., L. C. Sheldahl, M. Park, J. R. Miller, and R. T. Moon. 2000. The Wnt/Ca2+ pathway: a new vertebrate Wnt signaling pathway takes shape. Trends Genet. 16: 279-283. (Pubitemid 30389591)
32. Bradley, E. W., and M. H. Drissi. 2010. WNT5A regulates chondrocyte differentiation through differential use of the CaN/NFAT and IKK/NF-kappaB pathways. Mol. Endocrinol. 24: 1581-1593.
33. Spencer, G. J., J. C. Utting, S. L. Etheridge, T. R. Arnett, and P. G. Genever. 2006. Wnt signalling in osteoblasts regulates expression of the receptor activator of NFkappaB ligand and inhibits osteoclastogenesis in vitro. J. Cell Sci. 119: 1283-1296.
34. Tickenbrock, L., J. Schwäble, A. Strey, B. Sargin, S. Hehn, M. Baas, C. Choudhary, V. Gerke, W. E. Berdel, C. Müller-Tidow, and H. Serve. 2006. Wnt signaling regulates transendothelial migration of monocytes. J. Leukoc. Biol. 79: 1306-1313. (Pubitemid 44835566)
35. Thiele, A., M. Wasner, C. Müller, K. Engeland, and S. Hauschildt. 2001. Regulation and possible function of beta-catenin in human monocytes. J. Immunol. 167: 6786-6793. (Pubitemid 33144169)
36. Topol, L., X. Jiang, H. Choi, L. Garrett-Beal, P. J. Carolan, and Y. Yang. 2003. Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3-independent beta-catenin degradation. J. Cell Biol. 162: 899-908. (Pubitemid 37087729)
37. Nemeth, M. J., L. Topol, S. M. Anderson, Y. Yang, and D. M. Bodine. 2007. Wnt5a inhibits canonical Wnt signaling in hematopoietic stem cells and enhances repopulation. Proc. Natl. Acad. Sci. USA 104: 15436-15441. (Pubitemid 47502935)
38. Liu, X., M. Yao, N. Li, C. Wang, Y. Zheng, and X. Cao. 2008. CaMKII promotes TLR-triggered proinflammatory cytokine and type I interferon production by directly binding and activating TAK1 and IRF3 in macrophages. Blood 112: 4961-4970.
39. Kawai, T., and S. Akira. 2007. Signaling to NF-kappaB by Toll-like receptors. Trends Mol. Med. 13: 460-469.
40. Bartz, H., N. M. Avalos, A. Baetz, K. Heeg, and A. H. Dalpke. 2006. Involvement of suppressors of cytokine signaling in toll-like receptor-mediated block of dendritic cell differentiation. Blood 108: 4102-4108. (Pubitemid 44913281)
41. Wölfle, S. J., J. Strebovsky, H. Bartz, A. Sähr, C. Arnold, C. Kaiser, A. H. Dalpke, and K. Heeg. 2011. PD-L1 expression on tolerogenic APCs is controlled by STAT-3. Eur. J. Immunol. 41: 413-424.
42. Torres-Aguilar, H., S. R. Aguilar-Ruiz, G. González-Pérez, R. Munguía, S. Bajaña, M. A. Meraz-Ríos, and C. Sánchez-Torres. 2010. Tolerogenic dendritic cells generated with different immunosuppressive cytokines induce antigen-specific anergy and regulatory properties in memory CD4+ T cells. J. Immunol. 184: 1765-1775.
43. Chamorro, S., J. J. García-Vallejo, W. W. Unger, R. J. Fernandes, S. C. Bruijns, S. Laban, B. O. Roep, B. A. 't Hart, and Y. van Kooyk. 2009. TLR triggering on tolerogenic dendritic cells results in TLR2 up-regulation and a reduced proinflammatory immune program. J. Immunol. 183: 2984-2994.
44. Dimitriou, I. D., L. Clemenza, A. J. Scotter, G. Chen, F. M. Guerra, and R. Rottapel. 2008. Putting out the fire: coordinated suppression of the innate and adaptive immune systems by SOCS1 and SOCS3 proteins. Immunol. Rev. 224: 265-283.
45. Li, Y., N. Chu, A. Rostami, and G. X. Zhang. 2006. Dendritic cells transduced with SOCS-3 exhibit a tolerogenic/DC2 phenotype that directs type 2 Th cell differentiation in vitro and in vivo. J. Immunol. 177: 1679-1688. (Pubitemid 44092504)
46. Kuo, P. L., J. Y. Hung, S. K. Huang, S. H. Chou, D. E. Cheng, Y. J. Jong, C. H. Hung, C. J. Yang, Y. M. Tsai, Y. L. Hsu, and M. S. Huang. 2011. Lung cancer-derived galectin-1 mediates dendritic cell anergy through inhibitor of DNA binding 3/IL-10 signaling pathway. J. Immunol. 186: 1521-1530.
47. Gratchev, A., J. Kzhyshkowska, S. Kannookadan, M. Ochsenreiter, A. Popova, X. Yu, S. Mamidi, E. Stonehouse-Usselmann, I. Muller-Molinet, L. Gooi, and S. Goerdt. 2008. Activation of a TGF-beta-specific multistep gene expression program in mature macrophages requires glucocorticoid-mediated surface expression of TGF-beta receptor II. J. Immunol. 180: 6553-6565.
48. Pastille, E., S. Didovic, D. Brauckmann, M. Rani, H. Agrawal, F. U. Schade, Y. Zhang, and S. B. Flohé. 2011. Modulation of dendritic cell differentiation in the bone marrow mediates sustained immunosuppression after polymicrobial sepsis. J. Immunol. 186: 977-986.
49. Domínguez, P. M., and C. Ardavín. 2010. Differentiation and function of mouse monocyte-derived dendritic cells in steady state and inflammation. Immunol. Rev. 234: 90-104.
50. Cheong, C., I. Matos, J. H. Choi, D. B. Dandamudi, E. Shrestha, M. P. Longhi, K. L. Jeffrey, R. M. Anthony, C. Kluger, G. Nchinda, et al. 2010. Microbial stimulation fully differentiates monocytes to DC-SIGN/CD209(+) dendritic cells for immune T cell areas. Cell 143: 416-429.